Skip to main content

Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS

Jennings Headshot
Talking Therapeutics
11/14/2024
In this installment of Talking Therapeutics, we discuss a new study that explores the effect of various interventions aimed at combating sedentary behavior on blood pressure and pulse wave velocity (PWV), a key marker of arterial stiffness.
In this installment of Talking Therapeutics, we discuss a new study that explores the effect of various interventions aimed at combating sedentary behavior on blood pressure and pulse wave velocity (PWV), a key marker of arterial stiffness.
In this installment of Talking...
11/14/2024
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
11/08/2024
In this installment of Talking Therapeutics, we discuss new data comparing empagliflozin and dapagliflozin in patients with diabetes that show no difference in cardiovascular outcomes, underscoring the need for further studies.
In this installment of Talking Therapeutics, we discuss new data comparing empagliflozin and dapagliflozin in patients with diabetes that show no difference in cardiovascular outcomes, underscoring the need for further studies.
In this installment of Talking...
11/08/2024
Pharmacy Learning Network
douglas jennings
Commentary
10/07/2021
“As the number of HIV treatment options have burgeoned and patient management has democratized well beyond HIV specialists into fields such as primary and family care, clinicians are compelled to remain abreast of key practice updates,” says...
“As the number of HIV treatment options have burgeoned and patient management has democratized well beyond HIV specialists into fields such as primary and family care, clinicians are compelled to remain abreast of key practice updates,” says...
“As the number of HIV treatment...
10/07/2021
First Report Managed Care
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
06/02/2022
In the newest installment of Talking Therapeutics, Dr Jennings shares research into whether electronic health record alerts can improve the prescription of medical therapy.
In the newest installment of Talking Therapeutics, Dr Jennings shares research into whether electronic health record alerts can improve the prescription of medical therapy.
In the newest installment of...
06/02/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
03/16/2023
Dr Jennings continues his recap of ACC.23 in this week’s issue of Talking Therapeutics, highlighting data from 2 trials focused on a new PSCK9 inhibitor and anticoagulation in patients with COVID-19.
Dr Jennings continues his recap of ACC.23 in this week’s issue of Talking Therapeutics, highlighting data from 2 trials focused on a new PSCK9 inhibitor and anticoagulation in patients with COVID-19.
Dr Jennings continues his recap...
03/16/2023
Pharmacy Learning Network
Jennings Headshot
Talking Therapeutics
02/09/2024
In this installment of Talking Therapeutics, Dr Jennings explores the cardiovascular advantages associated with plant-based diets. He delves into research findings supporting this assertion and shares practical recommendations for patients...
In this installment of Talking Therapeutics, Dr Jennings explores the cardiovascular advantages associated with plant-based diets. He delves into research findings supporting this assertion and shares practical recommendations for patients...
In this installment of Talking...
02/09/2024
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
07/07/2021
Dr Jennings discusses the latest updates in diabetes care for this week’s edition of Talking Therapeutics—highlighting data from the American Diabetes Association’s annual Scientific Sessions.
Dr Jennings discusses the latest updates in diabetes care for this week’s edition of Talking Therapeutics—highlighting data from the American Diabetes Association’s annual Scientific Sessions.
Dr Jennings discusses the latest...
07/07/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
12/29/2021
Dr Jennings wraps up 2021, reviewing this year's Talking Therapeutics installments and inviting readers to leave feedback on what topics to cover in 2022.
Dr Jennings wraps up 2021, reviewing this year's Talking Therapeutics installments and inviting readers to leave feedback on what topics to cover in 2022.
Dr Jennings wraps up 2021,...
12/29/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
09/02/2022
In the latest installment of Talking Therapeutics, Dr Jennings shares new data on SGLT2 inhibitors and diuretics presented at this year's European Society of Cardiology meeting.
In the latest installment of Talking Therapeutics, Dr Jennings shares new data on SGLT2 inhibitors and diuretics presented at this year's European Society of Cardiology meeting.
In the latest installment of...
09/02/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
06/16/2023
In the latest installment of Talking Therapeutics, Dr Jennings discusses the impact of SGLT2 inhibitors on ischemic stroke in patients with atrial fibrillation and emphasizes the need for further research.
In the latest installment of Talking Therapeutics, Dr Jennings discusses the impact of SGLT2 inhibitors on ischemic stroke in patients with atrial fibrillation and emphasizes the need for further research.
In the latest installment of...
06/16/2023
Pharmacy Learning Network